Population based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high grade serous ovarian cancer
Honglin Song, Ed Dicks, Jonathan P. Tyrer, Maria Intermaggio, Georgia Chenevix-Trench, David D Bowtell, Nadia Traficante, AOCS Group, James D. Brenton, Teodora Goranova, Karen Hosking, Anna Piskorz, Elke Van Oudenhove, Jennifer Anne Doherty, Holly R. Harris, Mary Anne Rossing, Matthias Dürst, Thilo Dörk, Natalia V. Bogdanova, Francesmary Modugno, Kirsten B. Moysich, Kunle Odunsi, Roberta B. Ness, Beth Y. Karlan, Jenny Lester, Allan Jensen, Susanne K. Kjaer, Estrid Høgdall, Ian Campbell, Conxi Lazaro, Miquel Angel Pujana, Julie M. Cunningham, Robert A. Vierkant, Stacey J. Winham, Michelle A.T. Hildebrandt, Chad Huff, Donghui Li, Xifeng Wu, Yao Yu, Jennifer B. Permuth, Douglas A. Levine, Joellen M. Schildkraut, Marjorie J. Riggan, Andrew Berchuck, Penelope M. Webb, OPAL Study Group, Cezary Cybulski, Jacek Gronwald, Anna Jakubowska, Jan Lubiński, Jennifer Alsop, Patricia A. Harrington, Isaac Chan, Usha Menon, Celeste L. Pearce, Anna H. Wu, Anna de Fazio, Catherine J. Kennedy, Ellen L. Goode, Susan J. Ramus, Simon A. Gayther, Paul D.P. Pharoah
medRxiv 19011924; doi: https://doi.org/10.1101/19011924